The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anaemic patients with chronic kidney disease not on renal replacement therapy.
Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease.
- Chronic Kidney Failure
Treatment, Randomised, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study.
Eligibility & Criteria
- Ages Eligible for Study: 18 years and older
Genders Eligible for Study:
Chronic kidney disease
Anaemia (Hb 8 – 11.5 g/dl)
Age above 18 years
Signed informed consent
Rapid progression of kidney disease
Need for dialysis
Roland M Schaefer, MD
University Hospital Muenster
Westphalia University Hospital Muenster